Patent details

EP4370116 Title: AFICAMTEN DOSAGE REGIMENS FOR TREATING OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

Basic Information

Publication number:
EP4370116
PCT Application Number:
US2022073808
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP227539533
PCT Publication Number:
WO2023288324
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AFICAMTEN DOSAGE REGIMENS FOR TREATING OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
French Title of Invention:
SCHÉMAS POSOLOGIQUES D'AFICAMTEN POUR LE TRAITEMENT DE LA CARDIOMYOPATHIE HYPERTROPHIQUE OBSTRUCTIVE
German Title of Invention:
AFICAMTEN-DOSIERUNGSREGIME ZUR BEHANDLUNG DER OBSTRUKTIVEN HYPERTROPHISCHEN KARDIOMYOPATHIE
SPC Number:

Dates

Filing date:
15/07/2022
Grant date:
15/01/2025
EP Publication Date:
22/05/2024
PCT Publication Date:
19/01/2023
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/01/2025
EP B1 Publication Date:
15/01/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/07/2042
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/01/2025
 
 

Name:
Cytokinetics, Inc.
Address:
350 Oyster Point Blvd, South San Francisco CA 94080, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
24/01/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
MALIK, Fady
Address:
United States (US)

2

Name:
ROBERTSON, Laura Ann
Address:
United States (US)

3

Name:
KUPFER, Stuart
Address:
United States (US)

4

Name:
HEITNER, Stephen B.
Address:
United States (US)

5

Name:
WOHLTMAN, Qi
Address:
United States (US)

6

Name:
OSMUKHINA, Anna
Address:
United States (US)

7

Name:
MENG, Lixin
Address:
United States (US)

Priority

1

Priority Number:
202163203333 P
Priority Date:
16/07/2021
Priority Country:
United States (US)

2

Priority Number:
202263299753 P
Priority Date:
14/01/2022
Priority Country:
United States (US)

3

Priority Number:
202263305609 P
Priority Date:
01/02/2022
Priority Country:
United States (US)

4

Priority Number:
202263331197 P
Priority Date:
14/04/2022
Priority Country:
United States (US)

5

Priority Number:
202263343975 P
Priority Date:
19/05/2022
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4245; A61K 31/4402; A61K 45/06; A61P 9/00; A61K 9/00;

Publication

European Patent Bulletin

1

Issue number:
202503
Publication date:
15/01/2025
Description:
Grant (B1)

2

Issue number:
202508
Publication date:
19/02/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
5
Annual Fee Amount:
52 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/07/2025
Last Annual Fee Paid Number:
4
Last Annual Fee Paid Amount:
41 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
24/01/2025 Power Of Attorney 1
24/01/2025 Outgoing Correspondence 1